Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non―Small-Cell Lung Cancer: The NVALT-4 Study
- Author
- GROEN, Harry J. M1 ; SIETSMA, Hannie1 ; HILTERMANN, T. Jeroen N1 ; VAN DEN BORNE, Ben E. E. M8 ; SCHRAMEL, Franz M. N. H9 ; VINCENT, Andrew3 ; HOCHSTENBAG, Monique M. H4 ; VAN PUTTEN, John W. G2 ; VAN DEN BERG, Anke1 ; DALESIO, Otilia3 ; BIESMA, Bonne5 ; SMIT, Hans J. M6 ; TERMEER, Arien7
[1] University Medical Center Groningen, Netherlands
[2] Martini Hospital, Groningen, Netherlands
[3] Netherlands Cancer Institute, Amsterdam, Netherlands
[4] University Medical Center, Maastricht, Netherlands
[5] Jeroen Bosch Hospital, s'Hertogenbosch, Netherlands
[6] Rijn- state Hospital, Arnhem, Netherlands
[7] Canisius Wilhelmina Hospital, Nijmegen, Netherlands
[8] Catharina Hospital, Eindhoven, Netherlands
[9] St Antonius Hospital, Nieuwegein, Netherlands - Source
Journal of clinical oncology. 2011, Vol 29, Num 32, pp 4320-4326, 7 p ; ref : 25 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- American Society of Clinical Oncology, Alexandria, VA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Cancer du poumon Cancérologie Carboplatine Carcinome non petite cellule bronchopulmonaire Cyclooxygenase 2 Célécoxib Docétaxel Essai clinique phase III Homme Marqueur biologique Placebo Randomisation Stade avancé Traitement Antimitotique Cancer Dérivé du taxane Enzyme Inhibiteur cyclooxygenase 2 Inhibiteur enzyme Oxidoreductases Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Platine II Complexe Prostaglandin-endoperoxide synthase Tumeur maligne
- Keyword (en)
- Antineoplastic agent Lung cancer Cancerology Carboplatin non-small cell lung carcinoma Cyclooxygenase 2 Celecoxib Docetaxel Phase III trial Human Biological marker Placebo Randomization Advanced stage Treatment Antimitotic Cancer Taxane derivatives Enzyme Cyclooxygenase 2 inhibitor Enzyme inhibitor Oxidoreductases Respiratory disease Bronchus disease Lung disease Platinum II Complexes Prostaglandin-endoperoxide synthase Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del pulmón Cancerología Carboplatino Carcinoma no pequeňa célula bronchopulmonar Cyclooxygenase 2 Celecoxib Docetaxel Ensayo clínico fase III Hombre Marcador biológico Placebo Aleatorización Estadio avanzado Tratamiento Antimitótico Cáncer Taxane derivado Enzima Inhibidor cyclooxygenase 2 Inhibidor enzima Oxidoreductases Aparato respiratorio patología Bronquio patología Pulmón patología Platino II Complejo Prostaglandin-endoperoxide synthase Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pulmonology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24758274
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2011.35.5214 
https://dx.doi.org/10.1200/JCO.2011.35.5214
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.35.5214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:2:\"32\";s:8:\"\u0000*\u0000spage\";s:4:\"4320\";s:8:\"\u0000*\u0000epage\";s:4:\"4326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GROEN\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Harry J. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"SIETSMA, Hannie\";i:1;s:23:\"HILTERMANN, T. Jeroen N\";i:2;s:26:\"VAN DEN BORNE, Ben E. E. M\";i:3;s:23:\"SCHRAMEL, Franz M. N. H\";i:4;s:15:\"VINCENT, Andrew\";i:5;s:25:\"HOCHSTENBAG, Monique M. H\";i:6;s:21:\"VAN PUTTEN, John W. G\";i:7;s:18:\"VAN DEN BERG, Anke\";i:8;s:15:\"DALESIO, Otilia\";i:9;s:13:\"BIESMA, Bonne\";i:10;s:15:\"SMIT, Hans J. M\";i:11;s:14:\"TERMEER, Arien\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.35.5214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:2:\"32\";s:8:\"\u0000*\u0000spage\";s:4:\"4320\";s:8:\"\u0000*\u0000epage\";s:4:\"4326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GROEN\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Harry J. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"SIETSMA, Hannie\";i:1;s:23:\"HILTERMANN, T. Jeroen N\";i:2;s:26:\"VAN DEN BORNE, Ben E. E. M\";i:3;s:23:\"SCHRAMEL, Franz M. N. H\";i:4;s:15:\"VINCENT, Andrew\";i:5;s:25:\"HOCHSTENBAG, Monique M. H\";i:6;s:21:\"VAN PUTTEN, John W. G\";i:7;s:18:\"VAN DEN BERG, Anke\";i:8;s:15:\"DALESIO, Otilia\";i:9;s:13:\"BIESMA, Bonne\";i:10;s:15:\"SMIT, Hans J. M\";i:11;s:14:\"TERMEER, Arien\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.35.5214\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.35.5214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:2:\"32\";s:8:\"\u0000*\u0000spage\";s:4:\"4320\";s:8:\"\u0000*\u0000epage\";s:4:\"4326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GROEN\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Harry J. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"SIETSMA, Hannie\";i:1;s:23:\"HILTERMANN, T. Jeroen N\";i:2;s:26:\"VAN DEN BORNE, Ben E. E. M\";i:3;s:23:\"SCHRAMEL, Franz M. N. H\";i:4;s:15:\"VINCENT, Andrew\";i:5;s:25:\"HOCHSTENBAG, Monique M. H\";i:6;s:21:\"VAN PUTTEN, John W. G\";i:7;s:18:\"VAN DEN BERG, Anke\";i:8;s:15:\"DALESIO, Otilia\";i:9;s:13:\"BIESMA, Bonne\";i:10;s:15:\"SMIT, Hans J. M\";i:11;s:14:\"TERMEER, Arien\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.35.5214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:2:\"32\";s:8:\"\u0000*\u0000spage\";s:4:\"4320\";s:8:\"\u0000*\u0000epage\";s:4:\"4326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GROEN\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Harry J. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"SIETSMA, Hannie\";i:1;s:23:\"HILTERMANN, T. Jeroen N\";i:2;s:26:\"VAN DEN BORNE, Ben E. E. M\";i:3;s:23:\"SCHRAMEL, Franz M. N. H\";i:4;s:15:\"VINCENT, Andrew\";i:5;s:25:\"HOCHSTENBAG, Monique M. H\";i:6;s:21:\"VAN PUTTEN, John W. G\";i:7;s:18:\"VAN DEN BERG, Anke\";i:8;s:15:\"DALESIO, Otilia\";i:9;s:13:\"BIESMA, Bonne\";i:10;s:15:\"SMIT, Hans J. M\";i:11;s:14:\"TERMEER, Arien\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2011.35.5214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"29\";s:8:\"\u0000*\u0000issue\";s:2:\"32\";s:8:\"\u0000*\u0000spage\";s:4:\"4320\";s:8:\"\u0000*\u0000epage\";s:4:\"4326\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GROEN\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Harry J. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:15:\"SIETSMA, Hannie\";i:1;s:23:\"HILTERMANN, T. Jeroen N\";i:2;s:26:\"VAN DEN BORNE, Ben E. E. M\";i:3;s:23:\"SCHRAMEL, Franz M. N. H\";i:4;s:15:\"VINCENT, Andrew\";i:5;s:25:\"HOCHSTENBAG, Monique M. H\";i:6;s:21:\"VAN PUTTEN, John W. G\";i:7;s:18:\"VAN DEN BERG, Anke\";i:8;s:15:\"DALESIO, Otilia\";i:9;s:13:\"BIESMA, Bonne\";i:10;s:15:\"SMIT, Hans J. M\";i:11;s:14:\"TERMEER, Arien\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:213:\"Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non\u2015Small-Cell Lung Cancer: The NVALT-4 Study\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
